I am an orthopaedic surgeon dedicated to the treatment of children and adults who have bone or soft tissue tumors located in the extremities, pelvis, and sacrum. I am part of a multidisciplinary team that includes other experts in this field (pathologists, medical oncologists, radiation oncologists, and other surgical specialists) — all of whom share the ultimate goal of providing the best care to each individual patient. Team approach has substantially improved the prognosis of musculoskeletal cancer and particularly sarcomas.
Effective tumor removal without amputation is today possible in most cases through the use of a limb-salvage reconstructive procedure, with special emphasis placed on providing these patients with functional and long-term durable limb reconstructions. My clinical practice includes management of benign and malignant musculoskeletal tumors, and reconstructive surgery of the pelvis and extremities for neoplastic and non-neoplastic conditions including complex total joint revision surgery.
My primary research focus is to improve treatment outcomes for children and adults affected by musculoskeletal cancer. This entails designing more-effective cooperative strategies of treatment and optimizing results of surgical management, including both limb-reconstructive surgery and amputations. Areas of particular interest are massive skeletal and joint reconstruction, severe bone loss, and use of new porous materials to restore bone.
I am member of numerous national and international scientific societies related to musculoskeletal oncology. I have trained and mentored several specialists in this field from all over the world.
- Clinical Expertise: Bone and Soft Tissue Sarcomas, Pediatric and Adult; Metastatic Cancer to Bone; Benign Bone Tumors; Pelvic and Sacral Tumors; Skeletal and Joint Reconstruction
- Languages Spoken: English; French; Italian; Spanish
- Education: MD, Bologna University Medical School (Bologna, Italy)
- Residencies: Istituto Ortopedico Rizzoli (Bologna, Italy)
- Fellowships: Istituto Ortopedico Rizzoli (Bologna, Italy); Mayo Clinic
- Board Certifications: Orthopaedic Surgery (Italy and Europe)
Selected Book Chapters
“Tratamiento conservador del osteosarcoma.” Boriani S, Ferruzzi A, Ferraro A, Fabbri N. In: Actualizaciones en Tumores Oseos Malignos, Proceedings 2nd Reunion Internacional de Cirugia Ortopedica. Fernandez Portal L, ed. Salamanca: 1989; 49-54.
“Il Registro Nazionale dei tumori maligni dell’osso.” Picci P, Fabbri N, Biagini R, Ruggieri P, Ferruzzi A, Casadei R. In: Recenti progressi nelle conoscenze e nel controllo dei tumori. E. Triggiani, G. Sammarco, G. Liguori, D. Carretti, C. Maltoni, eds., Bologna: Monduzzi Editore; 1990: 167-172
“Chemioterapia primaria dell’osteosarcoma: esperienza dell’Istituto Ortopedico Rizzoli.” Picci P, Ruggieri P, Fabbri N, Biagini R, Tella G, Casadei R, Ferraro A, De Cristofaro R. In: Oncologia in Italia negli anni 90: valutazione dell’esistente e prospettive. G. Rasà, S. Amato, C. Currò, G. Fallica, F.L. Paparo, L. Caldarola, D. Carretti, C. Maltoni, eds. Bologna: Monduzzi Editore; 1991: 797-806.
“Valutazione dei margini chirurgici nella chirurgia oncologica dell’apparato locomotore e recidive locali.” Fabbri N, De Cristofaro R, Ferruzzi A, Tella G, Biagini R. In: La Terapia Chirurgica delle Recidive. L. Docimo, ed. Napoli: Casa Editrice l’Antologia; 1992: 359-364.
“Resection of ischiopubic tumours (pelvic region 3).” Fabbri N, Mercuri M, Campanacci M. In: Surgical Techniques in Orthopaedics and Traumatology. DuParc J, ed. Paris: Elsevier; 2001.
“Musculoskeletal tumors and sports injuries.” Ayvaz M, Fabbri N. In: Sports Injuries. MN Doral et al., eds. Berlin: Springer-Verlag; 2011.
“Iliofemoral arthrodesis and pseudoarthrosis.” Fabbri N, O’Connor MI, Mercuri M, Sim FH: In: Master Techniques in Orthopaedic Surgery: Oncology and Complex Reconstruction. Philadelphia: Lippincott Williams & Wilkins; 2012: 13-29.
“Osteofibrous dysplasia.” Fabbri N, Turcotte R. In: Encyclopédie Médico-Chirurgicale: Appareil Locomoteur. Paris: Elsevier Masson; 2012
“Adamantinoma.” Turcotte R, Fabbri N: In: Encyclopédie Médico-Chirurgicale: Appareil Locomoteur. Paris: Elsevier Masson; 2012
“Surgical management of lower extremity bone sarcomas.” Nassif N, Mavrogenis AF , Fabbri N. In: Sarcoma Oncology: A Multidisciplinary Approach. Pollock RE, Baker LH, O’Sullivan B, Randall RL, eds. People’s Medical Publishing House-USA, Ltd: China. In press.
As home to one of the world’s top cancer research centers, Memorial Sloan Kettering is typically involved in more than 900 clinical trials at a given time. Currently, clinical trials focused on the conditions I treat are enrolling new patients. If you’re interested in joining a clinical trial, click to learn about the trial’s purpose, eligibility criteria, and how to get more information.Learn more
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more